Appraising the evidence: Applying sex- and gender-based analysis (SGBA) to cochrane systematic reviews on cardiovascular diseases

Journal of Women's Health

Volumn 19, Issue 5, 2010, Pages 997-1003

  Doull, Marion ^a   Runnels, Vivien E ^a   Tudiver, Sari ^b   Boscoe, Madeline ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b HEALTH CANADA   (Canada)

^c Canadian Women's Health Network and Women's Health Clinic   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ANALYTIC METHOD; ARTICLE; CARDIOVASCULAR DISEASE; COCHRANE LIBRARY; EVIDENCE BASED MEDICINE; MEDICAL RESEARCH; PRIORITY JOURNAL; SEX AND GENDER BASED ANALYSIS; SEX DIFFERENCE; SYSTEMATIC REVIEW;

CARDIOVASCULAR DISEASES; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; REVIEW LITERATURE AS TOPIC; SEX FACTORS;

EID: 77952386007     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1626     Document Type: Article

References (34)

1. Spitzer D. Gender and sex-based analysis in health research: A guide for CIHR researchers and reviewers. Ottawa: Canadian Institutes of Health Research, 2007.
2. Health Portfolio Sex and Gender-Based Analysis Working Group. Health Portfolio Sex and Gender-Based Analysis Policy, 2009. Currently available through the Bureau of Women's Health and Gender Analysis, Health Canada, Ottawa, Ontario K1A 0K9.
3. Keuken DG, Haafkens JA, Hellema MJ, Burgers JS, Moerman CJ. Incorporating a gender perspective into the development of clinical guidelines: A training course for guideline developers. Implementation Sci 2007;2:e1-e7.
4. National Institutes of Health. NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical research, amended, October 2001. Bethesda, Maryland, Office of Extramural Research. National Institutes of Health. Accessed from http:==grants.nih.gov=grants=funding=women-min=guidelines- amended-10-2001.htm.
5. Grady D, Chaput L, Kristof M. Diagnosis and treatment of coronary heart disease in women: Systematic reviews of evidence on selected topics. Rockville, MD: Agency for Health-care Research and Quality, 2003. AHRQ Publication No. 03-0035. Evidence Report=Technology Assessment No. 80.
6. Blauwet LA, Hayes SN, McManus D, Redberg RF, Walsh MN. Low rate of sex-specific result reporting in cardiovascular trials. Mayo Clin Proc 2007;82:166-170.
7. Verbrugge LM. Sex differences in complaints and diagnoses. J Behav Med 1980;3:327-355.
8. Gijsbers van Wijk CMTG, Huisman H, Kolk AM. Gender differences in physical symptoms and illness behavior: A health diary study. Soc Sci Med 1999;49:1061-1074.
9. Klein W. Cardiovascular disease at the turn of the millennium: Focus on Europe. Eur Heart J Suppl 2001;3(Suppl M): M2-M6.
10. Yerman T, Gan WQ, Sin DD. The influence of gender on the effects of aspirin in preventing myocardial infarction. BMC Med 2007;5:29(epub).
11. Durstine JL. Editorial: Gender differences in lipids and lipoproteins after cardiac rehabilitation. J Cardiopulmonary Rehabil Prev 2004;24:257-258.
12. Pilote L, Dasgupta K, Guru V, et al. A comprehensive view of sex-specific issues related to cardiovascular disease. Can Med Assoc J 2007;176:S1-44.
13. Kim C, Redberg RF, Pavlic T, Eagle KA. A systematic review of gender differences in mortality after coronary artery bypass graft surgery and percutaneous coronary interventions. Clin Cardiol 2007;30:491-495.
14. Fowler RA, Sabur N, Li P, et al. Sex- and age-based differences in the delivery and outcomes of critical care. Can Med Assoc J 2007;177:1513-1519.
15. Berger JS, Roncaglioni, MC, Avazini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascaulr events in women and men: A sex-specific meta-analysis of randomized controlled trials. JAMA 2006;295: 306-313.
16. Jackson L, Leclerc J, Erskine Y, Linden W. Getting the most out of cardiac rehabilitation: A review of referral and adherence predictors. Heart 2005;91:10-14.
17. Asthana S, Halliday J. Developing an evidence base for policies and interventions to address health inequalities: The analysis of "public health regimes." Milbank 2006;84:577-603.
18. Cochrane Collaboration authors. Glossary of terms in the Cochrane Collaboration. Version 4.2.5. Updated May 2005. The Cochrane Collaboration, 2005.
19. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions, version 5.0.0. Updated February 2008. Available at www.cochranehandbook.org The Cochrane Collaboration, 2008.
20. Tugwell P, de Savigny D, Hawker G, Robinson V. Applying clinical epidemiological methods to health equity: The equity effectiveness loop. BMJ 2006;332:358-361.
21. Mackenbach JP. Tackling inequalities in health: The need for building a systematic review evidence base. J Epidemiol Community Health 2003;57:162.
22. Hankivsky O, Blackwood E, Hunt R, et al. Gender, diversity and evidence-based decision making. Health Law Canada 2007;28:1-24.
23. Johnson SM, Karvonen CA, Phelps CL, Nader S, Sanborn BM. Assessment of analysis by gender in the Cochrane Reviews as related to treatment of cardiovascular disease. J Womens Health 2003;12:449-457.
24. Rothwell PM. External validity of randomised controlled trials: "To whom do the results of this trial apply?" Lancet 2005;365:82-93.
25. Health Canada. Exploring concepts of gender and health. Ottawa: Health Canada. Women's Health Bureau, 2003.
26. Donner L. Including gender in health planning - A guide for regional health authorities. Winnipeg: Prairie Women's Health Centre of Excellence, 2003.
27. Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO). International ethical guidelines for biomedical research involving human subjects. Geneva: Council for International Organizations of Medical Sciences, 2002.
28. Day A, Van Koughnett JA, Watson S. The Gender Lens Tool. Ontario Women's Health Council. 2007. Toronto, ON. Accessed from http:==www.genderandhealth.ca= en=modules=lens=index.jsp.
29. Grimshaw JM, Santesso N, Cumpston M, Mayhew A, McGowan J. Knowledge for knowledge translation: The role of the Cochrane Collaboration. J Contin Educ Health Prof 2006;26:55-62.
30. Bailey KR. Reporting of sex-specific results: A statistician's perspective. Mayo Clin Proc 2007;82:158.
31. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine reporting of subgroup analyses in clinical trials. N Engl J Med 2007;357:2189-2194.
32. Aulakh AK, Anand SS. Sex and gender subgroup analyses of randomized trials. The need to proceed with caution. Womens Health Issues 2007;17:342-350.
33. Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 1991;266:93-98.
34. Bierman AS. Sex matters: Gender disparities in quality and outcomes of care. Can Med Assoc J 2007;177:1520-1521.